Pharma 2018/19 globally, looks to upgrade a bit of their Corporate Reputation. In general patients groups which are familiar and even working/partnering with at least one pharma company regard the company better. Partnering with patients works very well! Although the part of collaboration in research studies stays disappointingly low, it is one of the best ideas to a sustainable business for pharma.
As for their marketing and pricing efforts, only 9% of the respondent patient grooups stated that pharma as a whole was "excellent" or "good" at having fair pricing policies", which is lower than in 2017!
There looks to be a trend that more information and enghagement leads to better understanding and comprehension of policies.
If the current company executives take this to heart, it might even be that a common effort to pricing regulation renders a more quick result to agreements with health authorities and payers in matters of marketing access!
Do try a project on co-creating efforts with patients!
See http://www.healthbusinessconsult.com/co-creation-in-health-care/ and http://slidesha.re/11MagxG